Does BRENTUXIMAB VEDOTIN Cause Malignant neoplasm progression? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Malignant neoplasm progression have been filed in association with BRENTUXIMAB VEDOTIN (ADCETRIS). This represents 2.1% of all adverse event reports for BRENTUXIMAB VEDOTIN.
200
Reports of Malignant neoplasm progression with BRENTUXIMAB VEDOTIN
2.1%
of all BRENTUXIMAB VEDOTIN reports
63
Deaths
63
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BRENTUXIMAB VEDOTIN?
Of the 200 reports, 63 (31.5%) resulted in death, 63 (31.5%) required hospitalization, and 23 (11.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRENTUXIMAB VEDOTIN. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does BRENTUXIMAB VEDOTIN Cause?
Off label use (1,370)
Neuropathy peripheral (695)
Pyrexia (693)
Febrile neutropenia (684)
Death (602)
Neutropenia (561)
Hodgkin's disease (512)
Nausea (392)
Diarrhoea (385)
Anaemia (374)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BRENTUXIMAB VEDOTIN Alternatives Have Lower Malignant neoplasm progression Risk?
BRENTUXIMAB VEDOTIN vs BREO ELLIPTA
BRENTUXIMAB VEDOTIN vs BREXANOLONE
BRENTUXIMAB VEDOTIN vs BREXPIPRAZOLE
BRENTUXIMAB VEDOTIN vs BREXUCABTAGENE AUTOLEUCEL
BRENTUXIMAB VEDOTIN vs BRIGATINIB